Comparative effectiveness of rivaroxaban versus a vitamin K antagonist in patients with renal impairment treated for non-valvular atrial fibrillation in Germany — A retrospective cohort study

Background: The risk of thromboembolic events is increased in patients with non-valvular atrial fibrillation (NVAF) and renal impairment. The risk of bleeding events is increased if these patients are treated with anticoagulants and further increased in those with active cancer. Methods: RELOAD, a r...

Full description

Bibliographic Details
Main Authors: Hendrik Bonnemeier, Maria Huelsebeck, Sebastian Kloss
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:International Journal of Cardiology: Heart & Vasculature
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906718301702